Active ingredientEntecavirCat. No. P-E059-001CAS 142217-69-4Family · Pharmaceutical analytical standards
Entecavir
A guanosine nucleoside analogue that blocks the replication of hepatitis B virus, approved in the United States in 2005 for the treatment of chronic hepatitis B. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, other impurities and synthesis intermediates.
Did you know?It was born in 1992 within a research programme against herpesviruses: only later was it found to be far more active against hepatitis B virus.
Go to the active ingredient →Active ingredientEntecavirCat. No. P-E059-001CAS 142217-69-4
Active ingredientEntecavir MonohydrateCat. No. P-E059-003CAS 209216-23-9
IntermediateEntecavir Intermediate 5Cat. No. P-E059-004CAS 142217-78-5
Pharmacopoeial impurityEntecavir EP Impurity FCat. No. P-E059-005CAS 649761-24-0
Pharmacopoeial impurityEntecavir EP Impurity ACat. No. P-E059-006CAS 1367369-78-5
Pharmacopoeial impurityEntecavir EP Impurity BCat. No. P-E059-007CAS 1367369-77-4
Pharmacopoeial impurityEntecavir EP Impurity B HClCat. No. P-E059-008
Pharmacopoeial impurityEntecavir EP Impurity CCat. No. P-E059-009CAS 2204369-23-1
Pharmacopoeial impurityEntecavir EP Impurity DCat. No. P-E059-010CAS 1367369-80-9
Pharmacopoeial impurityEntecavir EP Impurity D HClCat. No. P-E059-011
Pharmacopoeial impurityEntecavir EP Impurity ECat. No. P-E059-012CAS 2349444-69-3
MetaboliteEntecavir GlucuronideCat. No. P-E059-013
Impurity(1R,3R,4R)-EntecavirCat. No. P-E059-015CAS 1367369-76-3
Impurity(1R, 3S, 4S)-EntecavirCat. No. P-E059-016CAS 1333204-94-6
Impurity(1R,3R,4R)-Entecavir HClCat. No. P-E059-017
Impurity(1S,3S,4R)-EntecavirCat. No. P-E059-018CAS 1367369-79-6
Impurity1'-Epi-Entecavir-di-o-benzyl EtherCat. No. P-E059-019CAS 1354695-86-5
ImpurityEntecavir Impurity 1Cat. No. P-E059-020CAS 84868-56-4
Impurity4'-Epi-Entecavir-di-o-benzyl EtherCat. No. P-E059-021CAS 1354695-85-4
Impurity4-Dimethylsilyl EntecavirCat. No. P-E059-022CAS 870614-82-7
Impurity9-Benzyl-6-(benzyloxy)-9H-purin-2-amineCat. No. P-E059-023CAS 156422-39-8
ImpurityDibenzyl EntecavirCat. No. P-E059-024CAS 142217-81-0
Impurityent-EntecavirCat. No. P-E059-025CAS 188399-46-4
Impurityent-Entecavir-di-O-benzyl EtherCat. No. P-E059-026CAS 1354695-82-1
ImpurityEntecavir Impurity 2Cat. No. P-E059-027
ImpurityEntecavir Impurity 3Cat. No. P-E059-028
ImpurityEntecavir Impurity 4Cat. No. P-E059-029
ImpurityEntecavir Impurity 5Cat. No. P-E059-030
ImpurityEntecavir Impurity 6Cat. No. P-E059-031
ImpurityEntecavir Impurity 7Cat. No. P-E059-032
ImpurityEntecavir Impurity 8Cat. No. P-E059-033
ImpurityEntecavir Impurity 9Cat. No. P-E059-034
ImpurityEntecavir Impurity 10Cat. No. P-E059-035
ImpurityEntecavir Impurity 11Cat. No. P-E059-036
ImpurityEntecavir Impurity 12Cat. No. P-E059-037CAS 142217-79-6
ImpurityEntecavir Impurity 13Cat. No. P-E059-038
ImpurityEntecavir Impurity 14Cat. No. P-E059-039
ImpurityEntecavir Impurity 15 (Mixture of Diastereomers)Cat. No. P-E059-040
ImpurityEntecavir Impurity 16Cat. No. P-E059-041
ImpurityEntecavir Impurity 17Cat. No. P-E059-042
ImpurityEntecavir Impurity 18Cat. No. P-E059-043
ImpurityEntecavir Impurity 19Cat. No. P-E059-044CAS 110567-21-0
ImpurityEntecavir Impurity 20Cat. No. P-E059-045CAS 117641-39-1
ImpurityEntecavir Impurity 21Cat. No. P-E059-046CAS 1354695-79-6
ImpurityEntecavir Impurity 22Cat. No. P-E059-047CAS 1415118-52-3
ImpurityEntecavir Impurity 23Cat. No. P-E059-048CAS 1354715-30-2
ImpurityEntecavir Impurity 24Cat. No. P-E059-049CAS 110567-22-1
ImpurityEntecavir Impurity 25Cat. No. P-E059-050CAS 142217-77-4
ImpurityEntecavir Impurity 26Cat. No. P-E059-051CAS 1907700-40-6
ImpurityEntecavir Impurity 27Cat. No. P-E059-052
ImpurityEntecavir Impurity 28Cat. No. P-E059-053
ImpurityEntecavir Impurity 29Cat. No. P-E059-054CAS 873298-16-9
ImpurityEntecavir Impurity 30Cat. No. P-E059-055CAS 1345339-53-8
ImpurityEntecavir Impurity 31Cat. No. P-E059-056CAS 1661867-19-1
ImpurityEntecavir Impurity 32Cat. No. P-E059-057
ImpurityEntecavir Impurity 33Cat. No. P-E059-058
ImpurityEntecavir Impurity 34Cat. No. P-E059-059
ImpurityEntecavir Impurity 35Cat. No. P-E059-061
ImpurityEntecavir Impurity 36Cat. No. P-E059-062
ImpurityEntecavir Impurity 37Cat. No. P-E059-063
ImpurityEntecavir Impurity 38Cat. No. P-E059-064
ImpurityEntecavir Impurity 39Cat. No. P-E059-065
ImpurityEntecavir Impurity 40Cat. No. P-E059-066
ImpurityEntecavir Impurity 41Cat. No. P-E059-067
ImpurityEntecavir Impurity 42Cat. No. P-E059-068CAS 1354695-84-3
ImpurityEntecavir Impurity 43Cat. No. P-E059-069
ImpurityEntecavir Impurity 45Cat. No. P-E059-071
ImpurityFuroentecavirCat. No. P-E059-072CAS 1984788-96-6
Impurity4'-O-(Hydroxydimethylsilyl) EntecavirCat. No. P-E059-073
ImpurityEntecavir N-OxideCat. No. P-E059-075
ImpurityEntecavir-(R)-Methylethyl Carboxylic AcidCat. No. P-E059-076CAS 1415118-53-4
IntermediateEntecavir Intermediate 7Cat. No. P-E059-077CAS 142217-80-9No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
ImpurityEntecavir impurity F CRSEDQM code Y0001802Family EntecavirReference substanceEntecavir monohydrate CRSEDQM code Y0001800Family EntecavirNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.